Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 2

Status

Recruiting 4Completed 2Terminated 1

Sponsor Class

OTHER 107INDUSTRY 7OTHER_GOV 3NIH 3

Study Type

Interventional 4Observational 3

Sponsor

Cancer Type

Genitourinary 13Thoracic 10Gastrointestinal 7Dermatologic 6CNS 6Breast 6Other hematologic neoplasm 4Lymphoid 4Plasma cell 3Head & Neck 2Sarcoma 1Other neoplasm 1Other 1Myeloid 1Endocrine 1

Conditions

Colorectal Neoplasms 1463Pancreatic Neoplasms 833Stomach Neoplasms 692Carcinoma, Hepatocellular 647Carcinoma, Non-Small-Cell Lung 542Neoplasms 459Breast Neoplasms 369Ovarian Neoplasms 338Neoplasm Metastasis 337Colonic Neoplasms 332Esophageal Neoplasms 297Liver Neoplasms 266Melanoma 255Lung Neoplasms 246Squamous Cell Carcinoma of Head and Neck 210Cholangiocarcinoma 180Carcinoma, Renal Cell 180Prostatic Neoplasms 175Head and Neck Neoplasms 172Triple Negative Breast Neoplasms 163Rectal Neoplasms 160Endometrial Neoplasms 160Uterine Cervical Neoplasms 155Gastrointestinal Neoplasms 142Urinary Bladder Neoplasms 139Biliary Tract Neoplasms 135Gastrointestinal Stromal Tumors 108Sarcoma 105Esophageal Squamous Cell Carcinoma 102Small Cell Lung Carcinoma 95

Interventions

tislelizumab 1Bevacizumab 13-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
INDUSTRY × Disease × Gastrointestinal × Clear all
NCT06726161 2026-04-13

GPC3

RayzeBio, Inc.

Phase 1/2 Recruiting
590 enrolled
Gastrointestinal

Disease, Carcinoma, Hepatocellular

NCT07479381 2026-04-09

CLEAR

Harbinger Health

Terminated
14 enrolled
Gastrointestinal

Disease, Neoplasms, Colorectal Neoplasms

NCT07244705 2025-11-24

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

Anbogen Therapeutics, Inc.

Phase 1/2 Recruiting
66 enrolled
Gastrointestinal

Disease, Colorectal Neoplasms

NCT07069556 2025-11-21

ColoSense Post-Approval Study

Geneoscopy, Inc.

Recruiting
12,500 enrolled
Gastrointestinal

Disease, Colorectal Neoplasms

NCT05988645 2025-09-29

Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)

MiWEndo Solutions S.L.

Phase NA Recruiting
50 enrolled
Gastrointestinal

Disease, Colorectal Neoplasms

NCT05477836 2022-11-30

MiWEndo1

MiWEndo Solutions S.L.

Phase NA Completed
15 enrolled
Gastrointestinal

Disease, Colorectal Neoplasms

NCT02540850 2016-01-11

RESEPT

BioChain (Beijing) Science and Technology, Inc.

Completed
1,031 enrolled 13 charts
Gastrointestinal

Adenoma, Disease, Polyps, Wounds and Injuries, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡